Loading institutional data...
Loading institutional data...
Held by 414 of 5,944 reporting institutions (96th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 16%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash of $475M fully covers short-term debt of $0.
Mostly long-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $199.32 today, the market must believe free cash flow compounds 9.9%/yr for a decade (off $363M normalized FCF).
The market's 9.9% is more conservative than its 9-yr track record.
2-stage DCF · 0.04B shares · net debt $598M
mean 20.4% · volatility σ 47% · implied rate exceeded in 6/9 yrs
Central path = implied 9.9%/yr growth; shaded band = ±1σ (47%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 17% of free cash flow, leaving room to grow it and fund buybacks. Last year: $77M dividends + $787M buybacks = $864M returned on $443M FCF.
7 consecutive years of dividend increases · 9%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
EOD close · as of 2026-08-05 · 15d old
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.45B 100.0% | $2.28B 100.0% | $2.04B 100.0% | $1.87B 100.0% | $1.70B 100.0% | $1.39B 100.0% | $1.18B 100.0% | $1.02B 100.0% | $911.7M 100.0% | $798.6M 100.0% |
| Cost of Revenue | $952.9M 39.0% | $895.7M 39.4% | $843.5M 41.4% | $779.3M 41.7% | $698.4M 41.1% | $556.4M 40.0% | $483.1M 41.0% | $411.1M 40.3% | $386.6M 42.4% | $344.3M 43.1% |
| Selling, General & Admin | $334.0M 13.7% | $327.2M 14.4% | $355.8M 17.5% | $400.4M 21.4% | $318.4M 18.7% | $272.0M 19.6% | $210.7M 17.9% | $147.8M 14.5% | $129.8M 14.2% | $105.2M 13.2% |
| Total Operating Expenses | $1.94B 79.5% | $1.85B 81.5% | $1.81B 88.7% | $1.70B 91.0% | $1.44B 84.9% | $1.17B 84.5% | $989.4M 83.9% | $804.1M 78.8% | $741.9M 81.4% | $617.8M 77.4% |
| Operating Income | $526.6M 21.5% | $484.8M 21.3% | $230.6M 11.3% | $167.8M 9.0% | $257.0M 15.1% | $215.2M 15.5% | $189.6M 16.1% | $215.8M 21.2% | $169.8M 18.6% | $180.8M 22.6% |
| Other Income (Expense), net | -$27.6M -1.1% | $6.5M 0.3% | -$49.1M -2.4% | -$37.2M -2.0% | -$6.5M -0.4% | $67.8M 4.9% | $8.9M 0.8% | $17.1M 1.7% | $11.3M 1.2% | $44.1M 5.5% |
| Pretax Income | $495.7M 20.3% | $473.9M 20.8% | $174.1M 8.5% | $130.6M 7.0% | $250.5M 14.7% | $283.0M 20.4% | $198.5M 16.8% | $232.9M 22.8% | $181.1M 19.9% | $224.9M 28.2% |
| Income Tax Expense | $121.5M 5.0% | $104.0M 4.6% | $33.0M 1.6% | $56.5M 3.0% | $62.6M 3.7% | $59.7M 4.3% | $45.6M 3.9% | $47.8M 4.7% | $42.9M 4.7% | $63.7M 8.0% |
| Net Income | $374.2M 15.3% | $369.9M 16.3% | $141.1M 6.9% | $70.5M 3.8% | $193.3M 11.4% | $223.6M 16.1% | $152.0M 12.9% | $183.0M 17.9% | $136.9M 15.0% | $161.0M 20.2% |
| Per Share | ||||||||||
| EPS (Basic) | $8.93 | $8.64 | $3.31 | $1.65 | $4.50 | $5.22 | $3.56 | $4.30 | $3.21 | $3.74 |
| EPS (Diluted) | $8.87 | $8.58 | $3.29 | $1.64 | $4.45 | $5.18 | $3.52 | $4.25 | $3.18 | $3.72 |
| Weighted Avg Shares (Basic) | 41.9M | 42.8M | 42.6M | 42.6M | 43.0M | 42.9M | 42.7M | 42.6M | 42.7M | 43.0M |
| Weighted Avg Shares (Diluted) | 42.2M | 43.1M | 42.9M | 42.9M | 43.4M | 43.2M | 43.2M | 43.0M | 43.0M | 43.3M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Ranked against 878 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BSAC | $6.64T | — | — | — | — | — | — | — | — | — | 141 |
| V | $688.1B | — | — | 17.2× | 11.3% | — | 50.1% | 52.9% | 34.9% | — | 4,229 |
| MA | $516.3B | 34.5× | — | 15.7× | 16.4% | — | 45.6% | 193% | 57.6% | — | 3,430 |
| HBCYF | $346.1B | — | — | — | — | — | — | — | — | — | 2 |
| AXP | $239.4B | 22.7× | — | 5.8× | 6.4% | — | 26.2% | 32.4% | 11.9% | — | 2,787 |
| MBFJF | $239.1B | 0.1× | 0.1× | 0.0× | 9.5% | — | 14.6% | 8.8% | 8.8% | — | 1 |
| USOI | $195.8B | — | — | 9.8× | 30.7% | — | -20.3% | -10.7% | -1.9% | — | 13 |
| HDB | $182.5B | 22.9× | — | 7.1× | -98.6% | — | 30.8% | 8.8% | 4.5% | — | 570 |
| UBS | $179.0B | — | — | — | — | — | — | — | — | — | 660 |
| USML | $178.1B | — | — | — | — | — | — | — | — | — | 2 |
| BLK | $175.8B | 32.1× | — | 7.3× | 89.3% | — | 22.9% | 9.9% | 8.1% | — | 2,196 |
| SMFNF | $158.8B | — | — | — | — | — | — | — | — | — | 1 |
| CB | $137.9B | 13.7× | — | 2.3× | 6.5% | — | 17.4% | 14.0% | 11.3% | — | 2,002 |
| GLD | $131.4B | — | — | — | — | — | — | — | — | — | 3,072 |
| MZHOF | $129.2B | 0.1× | — | 0.0× | 7.6% | — | 13.2% | 10.7% | 3.7% | — | 2 |
| PGR | $124.7B | 11.1× | — | 1.4× | 16.3% | — | 12.9% | 37.3% | 30.4% | — | 1,685 |
| SPGI | $122.5B | 28.0× | 17.5× | 8.0× | 7.9% | 70.2% | 29.2% | 14.4% | 10.1% | 1.7× | 2,005 |
| VXZ | $116.9B | — | — | — | — | — | — | — | — | — | 12 |
| BNS | $109.5B | — | — | — | — | — | — | — | — | — | 488 |
| BX | $101.8B | 35.1× | — | 7.0× | 9.2% | — | 20.9% | 34.8% | 14.2% | — | 2,037 |
| PNC | $101.1B | 15.4× | — | 4.4× | 7.2% | — | 30.3% | 11.5% | 5.9% | — | 1,839 |
| BCLYF | $97.9B | — | — | — | — | — | — | — | — | — | 5 |
| CME | $95.2B | 23.7× | — | 14.6× | 6.4% | — | 62.5% | 14.2% | 14.2% | — | 1,699 |
| MRSH | $92.9B | 22.7× | 16.5× | 3.4× | 10.3% | — | 15.4% | 27.2% | 12.4% | 2.8× | 1,471 |
| ICE | $85.0B | 26.0× | 20.2× | 6.7× | 7.5% | — | 26.2% | 11.5% | 6.8% | 3.8× | 1,641 |
| MORN | $7.9B | 22.5× | 11.9× | 3.2× | 7.5% | 61.0% | 15.3% | 30.6% | 16.3% | 1.5× | 414 |
Peers = companies sharing MORN's sector (Financial Services) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-08-05
Nothing notable to watch.
Where each multiple sits in its own 14-yr range · 20th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 40.3 | 41.0 | 40.0 | 41.1 | 41.7 | 41.4 | 39.4 | 39.0 |
| SG&A | 14.5 | 17.9 | 19.6 | 18.7 | 21.4 | 17.5 | 14.4 | 13.7 |
| Operating Income | 21.2 | 16.1 | 15.5 | 15.1 | 9.0 | 11.3 | 21.3 | 21.5 |
| Income Tax | 4.7 | 3.9 | 4.3 | 3.7 | 3.0 | 1.6 | 4.6 | 5.0 |
| Net Income | 17.9 | 12.9 | 16.1 | 11.4 | 3.8 | 6.9 | 16.3 | 15.3 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on MORN: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.